KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eli Lilly (LLY) Income towards Parent Company (2016 - 2026)

Eli Lilly filings provide 17 years of Income towards Parent Company readings, the most recent being $7.4 billion for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 168.07% to $7.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $25.3 billion, a 127.59% increase, with the full-year FY2025 number at $20.6 billion, up 94.9% from a year prior.
  • Income towards Parent Company hit $7.4 billion in Q1 2026 for Eli Lilly, up from $6.6 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $7.4 billion in Q1 2026 to a low of -$57.4 million in Q3 2023.
  • Median Income towards Parent Company over the past 5 years was $2.2 billion (2023), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Income towards Parent Company: crashed 103.95% in 2023 and later skyrocketed 1790.42% in 2024.
  • Eli Lilly's Income towards Parent Company stood at $1.9 billion in 2022, then increased by 12.98% to $2.2 billion in 2023, then skyrocketed by 101.43% to $4.4 billion in 2024, then soared by 50.52% to $6.6 billion in 2025, then grew by 11.42% to $7.4 billion in 2026.
  • The last three reported values for Income towards Parent Company were $7.4 billion (Q1 2026), $6.6 billion (Q4 2025), and $5.6 billion (Q3 2025) per Business Quant data.